Company news

Amneal Pharmaceuticals, Inc. news in 2019

Amneal Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors

December 15, 2019

Amneal Receives Abbreviated New Drug Application Approval for EluRyng™, the First Generic NuvaRing®

December 11, 2019

Amneal to Acquire Majority Interest in AvKARE, Enhancing Access to Growing Federal Healthcare Market

December 9, 2019

Amneal Announces the Approval and Launch of Generic Carafate®

December 2, 2019

Amneal Announces the Approval and Launch of Generic Revatio® for Oral Suspension and Generic Amicar® Tablets

December 1, 2019

Amneal Reports Third Quarter 2019 Financial Results

November 5, 2019

Amneal Enters into a Licensing Agreement with Kashiv BioSciences, LLC to Develop and Commercialize K127 for the Treatment of Myasthenia Gravis

November 5, 2019

Decks in 2019